Redefining Cardiac Antibody-Mediated Rejection With Donor-Specific Antibodies and Graft Dysfunction

医学 四分位间距 内科学 危险系数 心脏病学 射血分数 心力衰竭 置信区间
作者
Jason F. Goldberg,Xin Tian,Ann Bon,Yifei Xu,Eleanor F. Gerhard,Ruth Brower,Moon Kyoo Jang,Hyesik Kong,T. Andargie,W. Park,Samer S. Najjar,Inna Tchoukina,Keyur B. Shah,Steven Hsu,M.E. Rodrigo,Charles C. Marboe,Gerald J. Berry,Hannah A. Valantine,Palak Shah,Sean Agbor-Enoh
出处
期刊:Circulation-heart Failure [Lippincott Williams & Wilkins]
卷期号:17 (12)
标识
DOI:10.1161/circheartfailure.124.011592
摘要

BACKGROUND: Heart transplant recipients with donor-specific antibodies (DSAs) have an increased risk for antibody-mediated rejection. However, many patients with graft dysfunction and DSA do not have evidence of antibody-mediated rejection by endomyocardial biopsy (EMB). METHODS: Participants from this prospective, multicenter study underwent serial EMB, echocardiogram, DSA, and donor-derived cell-free DNA evaluations. Outcomes were defined as pAMR+ (pAMR≥1) or DSA+/left ventricle (LV) dysfunction (DSA presence+LVEF drop ≥10% to an LVEF≤50%). Cox regression evaluated the association between antibody-mediated rejection categories and death or sustained (for 3 months) reduction of LVEF to <50%. RESULTS: Two hundred sixteen patients (29% women, 39% Black race, median age 55 [interquartile range, 47–62] years) had 1488 EMB, 2792 DSA, 1821 echocardiograms, and 1190 donor-derived cell-free DNA evaluations. DSAs were present in 86 patients (40%). Fourteen patients had isolated pAMR+ episodes and 8 patients had isolated DSA+/LV dysfunction episodes; 2 patients had pAMR+ and then subsequently DSA+/LV dysfunction with pAMR+. Median %dd-cfDNA was significantly higher at diagnosis of pAMR+ (0.63% [interquartile range, 0.23–2.0]; P =0.0002), or DSA+/LV dysfunction (0.40% [interquartile range, 0.36–1.24]; P <0.0001), compared with patients without these outcomes (0.01% [interquartile range, 0.0001–0.10]). Both pAMR+ and DSA+/LV dysfunction were associated with long-term clinical outcome of death (n=18) or prolonged LV dysfunction (n=10): pAMR+ (hazard ratio, 2.8 [95% CI, 1.03–7.4]; P =0.043); DSA+/LV dysfunction (hazard ratio, 26.2 [95% CI, 9.6–71.3]; P <0.001); composite of both definitions (hazard ratio, 6.5 [95% CI, 2.9–14.3]; P <0.001). Patients who developed pAMR+ or DSA+/LV dysfunction within the first 6 months of transplant were more likely to die within 3 years posttransplant (hazard ratio, 3.9 [95% CI, 1.03–14.6]; P =0.031). CONCLUSIONS: Expanding the characterization of antibody-mediated rejection to include patients with DSA and concurrent allograft dysfunction identified DSA+ patients at risk for death and prolonged LV dysfunction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
YJ888发布了新的文献求助10
1秒前
今后应助Lu采纳,获得10
1秒前
EED发布了新的文献求助10
1秒前
88C真是太神奇啦完成签到,获得积分10
2秒前
2秒前
Rondab应助shuyi采纳,获得30
3秒前
酷酷飞烟发布了新的文献求助10
4秒前
5秒前
在水一方应助故意的靳采纳,获得50
6秒前
8秒前
忧郁的鱿鱼完成签到,获得积分10
8秒前
JamesPei应助lm采纳,获得10
10秒前
xww完成签到,获得积分10
10秒前
隐形曼青应助忐忑的阑香采纳,获得10
11秒前
秋半梦发布了新的文献求助10
12秒前
slp完成签到,获得积分20
19秒前
秋半梦完成签到,获得积分10
22秒前
bububusbu完成签到,获得积分10
22秒前
量子星尘发布了新的文献求助10
23秒前
我是老大应助TTm采纳,获得20
24秒前
科研通AI5应助Bressanone采纳,获得10
24秒前
坡坡大王发布了新的文献求助10
25秒前
华仔应助anna采纳,获得10
29秒前
carlin完成签到,获得积分10
31秒前
白子双完成签到,获得积分10
35秒前
FXQ123_范完成签到,获得积分10
35秒前
传奇3应助ran123456采纳,获得30
36秒前
keyan_baby完成签到,获得积分20
37秒前
39秒前
坡坡大王完成签到,获得积分10
40秒前
钱宇成关注了科研通微信公众号
40秒前
41秒前
Zayro完成签到,获得积分10
42秒前
43秒前
自信雅琴发布了新的文献求助10
43秒前
anna发布了新的文献求助10
46秒前
CodeCraft应助Lu采纳,获得10
47秒前
47秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989115
求助须知:如何正确求助?哪些是违规求助? 3531367
关于积分的说明 11253688
捐赠科研通 3269986
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882078
科研通“疑难数据库(出版商)”最低求助积分说明 809105